Skip to main content
Publications

Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of elivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization

By December 15, 2024June 9th, 2025No Comments